- Home
- KOD vs UVV Comparison
KOD vs UVV Comparison
Compare KOD & UVV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KOD | UVV |
|---|---|---|
| Founded | 2009 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 2018 | 1994 |
Fundamental Metrics
Financial Performance| Metric | KOD | UVV |
|---|---|---|
| Price | $23.70 | $52.63 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $28.29 | N/A |
| AVG Volume (30 Days) | ★ 510.9K | 179.2K |
| Earning Date | 01-01-0001 | 05-11-2026 |
| Dividend Yield | N/A | ★ 6.27% |
| EPS Growth | ★ 32.60 | N/A |
| EPS | N/A | ★ 3.02 |
| Revenue | N/A | ★ $2,922,924,000.00 |
| Revenue This Year | N/A | $0.67 |
| Revenue Next Year | N/A | $0.10 |
| P/E Ratio | ★ N/A | $17.31 |
| Revenue Growth | N/A | ★ 7.40 |
| 52 Week Low | $1.92 | $49.96 |
| 52 Week High | $31.18 | $67.33 |
Technical Indicators
Market Signals| Indicator | KOD | UVV |
|---|---|---|
| Relative Strength Index (RSI) | 43.43 | 43.67 |
| Support Level | $21.19 | $51.72 |
| Resistance Level | $26.21 | $54.01 |
| Average True Range (ATR) | 1.71 | 0.90 |
| MACD | -0.27 | -0.08 |
| Stochastic Oscillator | 14.96 | 36.52 |
Price Performance
Historical ComparisonAbout KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About UVV Universal Corporation
Universal Corp is an international leaf tobacco supplier. The company procures leaf tobacco from farmers, processes it, and sells it to companies that manufacture consumer tobacco products. Universal does not manufacture or sell any consumer products itself. The company's segments include Tobacco Operations and Ingredients Operations. It generates maximum revenue from the Tobacco Operations segment. Geographically, it derives a majority of revenue from the United States. The company operates in the USA, Belgium, China, Egypt, Philippines, Germany, and Other Countries with majority of revenue from USA.